|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6693 USD | +4.17% |
|
+2.00% | -24.24% |
Business description: Arch Biopartners Inc.

Sales by Activity: Arch Biopartners Inc.
| Fiscal Period: September | 2021 (CAD) | 2022 (CAD) | 2023 (CAD) | 2024 (CAD) | 2025 (CAD) |
|---|---|---|---|---|---|
Development of Innovative Technologies | 3.89M | 965K | 1.98M | 2.12M | 276K |
Geographical breakdown of sales: Arch Biopartners Inc.
| Fiscal Period: September | 2021 (CAD) | 2022 (CAD) | 2023 (CAD) | 2024 (CAD) | 2025 (CAD) |
|---|---|---|---|---|---|
Canada | 3.89M | 965K | 1.98M | 2.12M | 276K |
Executive Committee: Arch Biopartners Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Muruve
CTO | Chief Tech/Sci/R&D Officer | - | 03/03/1983 |
Richard Muruve
CEO | Chief Executive Officer | - | 03/03/1983 |
Andrew Bishop
DFI | Director of Finance/CFO | 60 | 31/03/2010 |
Composition of the Board of Directors: Arch Biopartners Inc.
| Director | Title | Age | Since |
|---|---|---|---|
Richard Rossman
BRD | Director/Board Member | - | 06/05/2010 |
Richard Muruve
BRD | Director/Board Member | - | 03/03/1983 |
Andrew Bishop
BRD | Director/Board Member | 60 | 31/03/2010 |
| Chairman | 62 | 14/01/2026 |
Company details: Arch Biopartners Inc.

Other Pharmaceuticals
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.17% | +2.00% | -50.55% | -60.63% | 43.01M | ||
| -1.68% | +0.31% | +18.79% | +210.92% | 926B | ||
| +0.23% | +1.15% | +57.18% | +54.19% | 586B | ||
| -2.47% | +2.74% | +15.64% | +49.30% | 412B | ||
| +0.16% | +3.81% | +25.60% | +32.26% | 382B | ||
| +0.55% | +5.59% | +32.73% | +35.58% | 326B | ||
| -0.44% | +4.01% | +33.14% | +60.33% | 317B | ||
| -0.72% | +1.16% | +44.90% | +10.65% | 302B | ||
| +0.45% | +1.40% | -47.02% | -36.77% | 218B | ||
| +1.18% | +2.85% | +28.76% | +58.25% | 201B | ||
| Average | +0.15% | +2.68% | +15.92% | +41.41% | 366.92B | |
| Weighted average by Cap. | -0.58% | +2.94% | +26.54% | +81.01% |
- Stock Market
- Equities
- ACHFF Stock
- Company Arch Biopartners Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















